CL2012001010A1 - Compuesto 4-[etil(dimetil)amonio]butanoato; procesos de preparacion de este compuesto; y su uso en el tratamiento de enfermedades cardiovasculares. - Google Patents

Compuesto 4-[etil(dimetil)amonio]butanoato; procesos de preparacion de este compuesto; y su uso en el tratamiento de enfermedades cardiovasculares.

Info

Publication number
CL2012001010A1
CL2012001010A1 CL2012001010A CL2012001010A CL2012001010A1 CL 2012001010 A1 CL2012001010 A1 CL 2012001010A1 CL 2012001010 A CL2012001010 A CL 2012001010A CL 2012001010 A CL2012001010 A CL 2012001010A CL 2012001010 A1 CL2012001010 A1 CL 2012001010A1
Authority
CL
Chile
Prior art keywords
compound
butanoate
dimethyl
ammonium
ethyl
Prior art date
Application number
CL2012001010A
Other languages
English (en)
Inventor
Ivars Kalvins
Maija Dambrova
Edgars Liepins
Osvalds Pugovics
Reinis Vilskersts
Janis Kuka
Solveiga Grinberga
Einars Loza
Original Assignee
Grindeks Jsc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grindeks Jsc filed Critical Grindeks Jsc
Publication of CL2012001010A1 publication Critical patent/CL2012001010A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPUESTO 4-[ETIL(DIMETIL)AMONIO]BUTANOATO QUE TIENE LA SIGUIENTE FORMULA PROCESOS DE PREPARACIÓN DE ESTE COMPUESTO; Y SU USO EN EL TRATAMIENTO DE ENFERMEDADES CARDIOVASCULARES.
CL2012001010A 2009-10-22 2012-04-20 Compuesto 4-[etil(dimetil)amonio]butanoato; procesos de preparacion de este compuesto; y su uso en el tratamiento de enfermedades cardiovasculares. CL2012001010A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-09-181A LV14345B (lv) 2009-10-22 2009-10-22 4-[Etil(dimetil)amonija]butanoāts un tā izmantošana kardiovaskulāro slimību ārstēšanai

Publications (1)

Publication Number Publication Date
CL2012001010A1 true CL2012001010A1 (es) 2012-08-31

Family

ID=43530044

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012001010A CL2012001010A1 (es) 2009-10-22 2012-04-20 Compuesto 4-[etil(dimetil)amonio]butanoato; procesos de preparacion de este compuesto; y su uso en el tratamiento de enfermedades cardiovasculares.

Country Status (33)

Country Link
US (2) US9278907B2 (es)
EP (1) EP2491005B1 (es)
JP (1) JP5552169B2 (es)
KR (1) KR101355417B1 (es)
CN (1) CN102666476B (es)
AR (1) AR081514A1 (es)
AU (1) AU2010309756B2 (es)
BR (1) BR112012009162B8 (es)
CA (1) CA2781499C (es)
CL (1) CL2012001010A1 (es)
CO (1) CO6531459A2 (es)
CU (1) CU20120065A7 (es)
DK (1) DK2491005T3 (es)
EA (1) EA020303B1 (es)
ES (1) ES2508117T3 (es)
GE (1) GEP20146123B (es)
HK (1) HK1169824A1 (es)
HR (1) HRP20140964T1 (es)
IL (1) IL219217A0 (es)
LV (1) LV14345B (es)
ME (1) ME01917B (es)
MX (1) MX2012004630A (es)
NZ (1) NZ599521A (es)
PE (1) PE20121473A1 (es)
PL (1) PL2491005T3 (es)
PT (1) PT2491005E (es)
RS (1) RS53620B1 (es)
SI (1) SI2491005T1 (es)
SM (1) SMT201400176B (es)
TN (1) TN2012000174A1 (es)
UA (1) UA107201C2 (es)
WO (1) WO2011048201A1 (es)
ZA (1) ZA201202916B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8565150B2 (en) * 2009-03-11 2013-10-22 At&T Mobility Ii Llc Architectural model for LTE (long term evolution) EPC (evolved packet core) deployment
RS55092B1 (sr) * 2011-04-27 2016-12-30 Grindeks Jsc Upotreba 3-karboksi-n-etil-n,n-dimetilpropan-1-aminijum soli u lečenju kardiovaskularne bolesti
DE102012109911A1 (de) 2011-10-19 2013-04-25 Electronics And Telecommunications Research Institute Energy harvesting device using electromagnetic interference signal and sensor system including the same
JO3117B1 (ar) * 2012-12-20 2017-09-20 Grindeks Jsc استعمال 3- كربوكسي- ن-إيثيل- ن، ن- ثاني ميثيل بروبان-1– أمينيوم أو ملح منه مقبول صيدلانياً في معالجة تصلب الشرايين
JO3333B1 (ar) * 2013-09-26 2019-03-13 Grindeks Jsc استعمال 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium أو ملح مقبول دوائيا منه للوقاية من السكري وعلاجه
CN107879944B (zh) * 2017-10-30 2020-05-22 杭州海尔希畜牧科技有限公司 一种制备丁基甜菜碱的方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1238868A (es) 1967-08-08 1971-07-14
SU997646A1 (ru) 1978-11-27 1983-02-23 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср Кормова добавка
IT1210935B (it) 1981-09-17 1989-09-29 Inst Orch Sinteza Akademi Nauk Composizione farmaceutica per il trattamento di malattie cardiovascolari.
IT1190280B (it) * 1986-04-24 1988-02-16 Sigma Tau Ind Farmaceuti Procedimento per la preparazione di gamma-butirrobetaina
US4933103A (en) * 1987-03-23 1990-06-12 Kao Corporation Bleaching composition
SU1680693A1 (ru) * 1987-03-25 1991-09-30 Институт Органического Синтеза Ан Латвсср Этил-3-(2,2-диметил-2-этилгидразиний)пропионат иодистый, про вл ющий антиаритмическую активность
JPH0291049A (ja) * 1988-09-21 1990-03-30 Lonza Ag ｒ―ブチロベタインの製造方法
JP3119430B2 (ja) * 1995-07-25 2000-12-18 大鵬薬品工業株式会社 水酸基ラジカル消去剤
LV11728B (en) 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
US5973026A (en) 1998-02-02 1999-10-26 Xerox Corporation Ink jet inks
JP2000239239A (ja) * 1999-02-22 2000-09-05 Kankyo Meneki Gijutsu Kenkyusho:Kk クロルメコート類縁化合物のハプテン化合物、抗体及び測定方法
CA2508094A1 (en) 2005-05-20 2006-11-20 Vivier Canada Inc. Composition for accelerating collagen synthesis
US7863274B2 (en) 2005-07-29 2011-01-04 Concert Pharmaceuticals Inc. Deuterium enriched analogues of tadalafil as PDE5 inhibitors
LV13705B (en) 2006-11-06 2008-07-20 Ivars Kalvins Process for producing high purity intermolecular salt of 3-carboxy-n,n,n-trimethyl-propane-1-amine hydroxide
JP4761265B2 (ja) 2007-10-17 2011-08-31 学校法人甲南学園 核酸合成を促進する化合物を含む組成物およびその利用、並びに当該化合物の製造方法
CN101538214A (zh) * 2009-04-24 2009-09-23 潍坊祥维斯化学品有限公司 生产γ-丁基甜菜碱及其盐酸盐的方法
WO2012146737A1 (en) * 2011-04-27 2012-11-01 Grindeks, A Joint Stock Company 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease

Also Published As

Publication number Publication date
UA107201C2 (uk) 2014-12-10
ME01917B (me) 2015-05-20
ES2508117T3 (es) 2014-10-16
NZ599521A (en) 2013-11-29
BR112012009162A2 (pt) 2020-08-18
EA020303B1 (ru) 2014-10-30
CU24114B1 (es) 2015-08-27
SMT201400176B (it) 2015-01-15
PL2491005T3 (pl) 2015-03-31
AU2010309756A1 (en) 2012-05-17
MX2012004630A (es) 2013-07-29
CU20120065A7 (es) 2012-06-29
HK1169824A1 (en) 2013-02-08
CA2781499A1 (en) 2011-04-28
CO6531459A2 (es) 2012-09-28
US20120220656A1 (en) 2012-08-30
SI2491005T1 (sl) 2014-12-31
BR112012009162B8 (pt) 2021-07-27
KR20120101634A (ko) 2012-09-14
JP2013508342A (ja) 2013-03-07
CN102666476B (zh) 2014-07-09
EP2491005B1 (en) 2014-07-23
PE20121473A1 (es) 2012-11-18
CA2781499C (en) 2015-03-24
WO2011048201A1 (en) 2011-04-28
EA201200514A1 (ru) 2012-09-28
LV14345A (lv) 2011-05-20
IL219217A0 (en) 2012-06-28
KR101355417B1 (ko) 2014-01-27
US9278907B2 (en) 2016-03-08
AU2010309756B2 (en) 2013-10-17
JP5552169B2 (ja) 2014-07-16
LV14345B (lv) 2011-07-20
GEP20146123B (en) 2014-07-25
TN2012000174A1 (en) 2013-12-12
EP2491005A1 (en) 2012-08-29
US9573882B2 (en) 2017-02-21
BR112012009162B1 (pt) 2021-02-02
AR081514A1 (es) 2012-10-03
RS53620B1 (en) 2015-04-30
US20160137589A1 (en) 2016-05-19
PT2491005E (pt) 2014-10-29
HRP20140964T1 (hr) 2014-12-05
ZA201202916B (en) 2013-05-29
CN102666476A (zh) 2012-09-12
DK2491005T3 (da) 2014-10-27

Similar Documents

Publication Publication Date Title
CR20120283A (es) Inhibidor de bromodominio de benzodiazepina
SMT201500148B (it) Composizioni per uso nel trattamento di infezioni virali
CL2014000630A1 (es) Una composicion que comprende 1) un compuesto derivado de nucleosido denominado como compuesto 10 y 2) un compuesto derivado de acido 5-tiofeno-2-carboxilico denominado como compuesto 5 o un compuesto derivado del ester metilico del acido carbamico denominado como compuesto 6; y su uso para el tratamiento profilactico o terapeutico de una infeccion por vhc.
CL2012000573A1 (es) Compuestos derivados de bifenil-pirrolidinil-imidazol; composicion farmaceutica que los comprende; su uso en el tratamiento de una infeccion viral por hcv.
CL2011000301A1 (es) Compuestos derivados de purina con actividad inmunomoduladora; composición farmacéutica que los comprende; y uso de ellos en el tratamiento de enfermedades alérgicas, rinitis alérgica, asma, enfermedades infecciosas y cáncer.
SMT201400008B (it) Uso di betanecolo per il trattamento di xerostomia
EA201170832A1 (ru) Пуриновые соединения
CO7111285A2 (es) Composiciones pesticidas y procesos relacionados con ellas
CL2008001123A1 (es) Compuestos derivados de acido lipoico; formulacion farmaceutica que lo comprende; y uso en el tratamiento del cancer.
EA201170295A1 (ru) ИНГИБИТОРЫ сМЕТ
ECSP10010722A (es) Compuestos orgánicos
BR112012014082A2 (pt) composições e métodos que compreendem variantes de protease
CL2011000527A1 (es) Compuestos derivados de benzofurano; composicion farmaceutica que los comprende;y su uso en el tratamiento de la hepatitis c.
BRPI0914682B8 (pt) compostos de heteroarila e composições compreendendo os referidos compostos
ES2570569T3 (es) Compuestos de benzoxazepina como inhibidores de la PI3K y métodos de uso
NO20080129L (no) Fremgangsmate for fremstilling av dihydrokinazoliner
CL2012001010A1 (es) Compuesto 4-[etil(dimetil)amonio]butanoato; procesos de preparacion de este compuesto; y su uso en el tratamiento de enfermedades cardiovasculares.
CL2011001331A1 (es) Clorhidrato de nalmefeno dihidratado; métodos para su preparación; composición farmacéutica que lo comprende; y uso para el tratamiento del alcoholismo.
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
IN2014CN03307A (es)
CL2008002295A1 (es) Compuestos derivados de tiazolida sustituidos con alquilsulfonilos; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
BRPI1015043A2 (pt) derivados de diazahomoadamantano e métodos de uso dos mesmos
BRPI1005670A8 (pt) composições adjuvantes e processos de uso.
ECSP11010812A (es) Complejo de mineral-aminoácido polisacárido
CL2009000119A1 (es) Compuestos derivados de amino-bencimidazoles sustituidos; composicion farmaceutica; y su uso en el tratamiento del alzheimer.